A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
العنوان: | A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study |
---|---|
المؤلفون: | Manal F. Abdelmalek, Ayako Suzuki, Willian Sanchez, Eric Lawitz, Claudia Filozof, Hyungjin Cho, Eunhye Baek, JaeDuk Choi, Seungjae Baek |
المصدر: | Contemporary Clinical Trials. 130:107176 |
بيانات النشر: | Elsevier BV, 2023. |
سنة النشر: | 2023 |
مصطلحات موضوعية: | Pharmacology (medical), General Medicine |
تدمد: | 1551-7144 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::b0297e468f57531a570dd8b6d57efe7dTest https://doi.org/10.1016/j.cct.2023.107176Test |
حقوق: | CLOSED |
رقم الانضمام: | edsair.doi...........b0297e468f57531a570dd8b6d57efe7d |
قاعدة البيانات: | OpenAIRE |